mRNA flu vaccines are making their way through clinical trials
The studies suggest that mRNA versions may be more effective than traditional flu shots
Flu vaccination remains a key public health strategy, but researchers continue to look for ways to improve the shot. Pfizer and Moderna have reported promising results for their mRNA flu vaccines in phase 3 clinical trials.
JEAN-CHRISTOPHE VERHAEGEN/AFP/Getty Images
This is a human-written story voiced by AI.